7449 related articles for article (PubMed ID: 2672685)
21. Desensitization of melanoma cells to autocrine TGF-beta isoforms.
Krasagakis K; Krüger-Krasagakes S; Fimmel S; Eberle J; Thölke D; von der Ohe M; Mansmann U; Orfanos CE
J Cell Physiol; 1999 Feb; 178(2):179-87. PubMed ID: 10048582
[TBL] [Abstract][Full Text] [Related]
22. Effects of various antineoplastic agents on an established human melanoma cell line (G-361).
García Reverte JM; Bernabeu Esclapez A; Muñoz Ramos J; Vicente Ortega V; Canteras Jordana M
Histol Histopathol; 1995 Jan; 10(1):79-84. PubMed ID: 7756747
[TBL] [Abstract][Full Text] [Related]
23. Recurrent lentigo maligna melanoma: regression associated with local azelaic acid 20%.
Vereecken P; Heenen M
Int J Clin Pract; 2002; 56(1):68-9. PubMed ID: 11831841
[TBL] [Abstract][Full Text] [Related]
24. Effect of melatonin on melanoma cells subjected to UVA and UVB radiation in In vitro studies.
Izykowska I; Gebarowska E; Cegielski M; Podhorska-Okolow M; Piotrowska A; Zabel M; Dziegiel P
In Vivo; 2009; 23(5):733-8. PubMed ID: 19779108
[TBL] [Abstract][Full Text] [Related]
25. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide.
Burres NS; Clement JJ
Cancer Res; 1989 Jun; 49(11):2935-40. PubMed ID: 2720652
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic activity of fusaric acid on human adenocarcinoma cells in tissue culture.
Fernandez-Pol JA; Klos DJ; Hamilton PD
Anticancer Res; 1993; 13(1):57-64. PubMed ID: 8476229
[TBL] [Abstract][Full Text] [Related]
27. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
Regenass U; Mett H; Stanek J; Mueller M; Kramer D; Porter CW
Cancer Res; 1994 Jun; 54(12):3210-7. PubMed ID: 8205541
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of pyridoxal treatment in controlling the growth of melanomas in cell culture and an animal pilot study.
Maksymowych AB; Robertson NM; Litwack G
Anticancer Res; 1993; 13(6A):1925-37. PubMed ID: 8297098
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of azelaic acid as a depigmenting and chemotherapeutic agent.
Robins EJ; Breathnach AS; Bashin YP; Ethridge L; Nazzaro-Porro M; Passi S; Picardo M
J Invest Dermatol; 1986 Aug; 87(2):293-4. PubMed ID: 3734479
[No Abstract] [Full Text] [Related]
30. [Combined effect of cisplatin and caffeine on murine B16-BL6 melanoma cells].
Yasutake H; Tsuchiya H; Sugihara M; Tomita K; Ueda Y; Tanaka M; Sasaki T
Gan To Kagaku Ryoho; 1989 May; 16(5):2031-8. PubMed ID: 2730093
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of DNA synthesis of melanoma cells by azelaic acid.
Leibl H; Stingl G; Pehamberger H; Korschan H; Konrad K; Wolff K
J Invest Dermatol; 1985 Nov; 85(5):417-22. PubMed ID: 4056455
[TBL] [Abstract][Full Text] [Related]
32. The stimulation of normal human melanocyte proliferation in vitro by melanocyte growth factor from bovine brain.
Wilkins L; Gilchrest BA; Szabo G; Weinstein R; Maciag T
J Cell Physiol; 1985 Mar; 122(3):350-61. PubMed ID: 3968191
[TBL] [Abstract][Full Text] [Related]
33. Cell cycle inhibition of HTLV-I transformed T cell lines by retinoic acid: the possible therapeutic use of thioredoxin reductase inhibitors.
U-Taniguchi Y; Furuke K; Masutani H; Nakamura H; Yodoi J
Oncol Res; 1995; 7(3-4):183-9. PubMed ID: 8555652
[TBL] [Abstract][Full Text] [Related]
34. In vitro anti-tumour activity of alpha-galactosylceramide-stimulated human invariant Valpha24+NKT cells against melanoma.
Kikuchi A; Nieda M; Schmidt C; Koezuka Y; Ishihara S; Ishikawa Y; Tadokoro K; Durrant S; Boyd A; Juji T; Nicol A
Br J Cancer; 2001 Sep; 85(5):741-6. PubMed ID: 11531261
[TBL] [Abstract][Full Text] [Related]
35. Role of ornithine decarboxylase in the regulation of cell growth by IL-1 and tumor necrosis factor.
Endo Y; Matsushima K; Onozaki K; Oppenheim JJ
J Immunol; 1988 Oct; 141(7):2342-8. PubMed ID: 2971724
[TBL] [Abstract][Full Text] [Related]
36. An evaluation of the effectiveness of azelaic acid as a depigmenting and chemotherapeutic agent.
Pathak MA; Ciganek ER; Wick M; Sober AJ; Farinelli WA; Fitzpatrick TB
J Invest Dermatol; 1985 Sep; 85(3):222-8. PubMed ID: 4031538
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory action of ganglioside GM3 on murine neuroblastoma cell proliferation: modulating effect of fetal calf serum.
Zhang C; Paller AS; Mirkin BL
Anticancer Res; 1995; 15(3):661-6. PubMed ID: 7645939
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxicity and mode of action of aliphatic dicarboxylic acids in L1210 lymphocytic leukemia cells.
Hall IH; Izydore RA; Warren AE; Barnes CR
Anticancer Res; 1999; 19(1A):205-11. PubMed ID: 10226544
[TBL] [Abstract][Full Text] [Related]
39. Low-dose retinoic acid enhances in vitro invasiveness of human oral squamous-cell-carcinoma cell lines.
Uchida D; Kawamata H; Nakashiro K; Omotehara F; Hino S; Hoque MO; Begum NM; Yoshida H; Sato M; Fujimori T
Br J Cancer; 2001 Jul; 85(1):122-8. PubMed ID: 11437413
[TBL] [Abstract][Full Text] [Related]
40. Influence of human leukocyte interferon (HuIFN-alpha/Le/) and cimetidine on the proliferation of cultured melanoma cells in vitro.
Flodgren P
Anticancer Res; 1985; 5(5):527-31. PubMed ID: 4062254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
